Literature DB >> 19013303

Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.

Bárbara Echiburú1, Francisco Pérez-Bravo, Manuel Maliqueo, Fernando Sánchez, Nicolás Crisosto, Teresa Sir-Petermann.   

Abstract

The aim of this study was to establish the frequency of gene CYP17 promoter polymorphism in women with polycystic ovary syndrome (PCOS) from a Chilean population and to examine the association of this polymorphism with body weight and estimate of insulin resistance in PCOS patient carriers and noncarriers of the A2 allelic variant. A total of 159 women with clinical and hormonal evidence of PCOS and 93 healthy women (HW) were evaluated. Diagnosis of PCOS was made according to the National Institutes of Health consensus criteria. In PCOS and HW, an oral glucose tolerance test was performed; and serum glucose and insulin were measured before the glucose load and 30, 60, 90, and 120 minutes after. Lipid profile and free fatty acid concentrations were determined in the basal sample. Insulin resistance was evaluated by homeostatic model assessment and insulin sensitivity index composite. A polymerase chain reaction-restriction fragment length polymorphism analysis was performed in all women to determine the A2 allele of the gene CYP17 promoter. The genotype frequency was similar between HW and PCOS women. No differences in anthropometric measurements and metabolic parameters were observed in HW carrier and noncarrier of the A2 variant. In PCOS women, an increase in body mass index, waist circumference, homeostatic model assessment of insulin resistance, and fasting insulin according to the A2 allele dosage was observed (P = .008, P = .016, P = .012, and P = .006, respectively). Polycystic ovary syndrome patient carriers of the A2 allele with a body mass index greater than 29.9 kg/m(2) showed an odds ratio of 9.1 (confidence interval, 3.0-27.4; P < .0001) for developing insulin resistance. These data suggest that the frequency of the A2 allele is similar between PCOS patients and HW; however, the presence of this gene defect in PCOS patients seems to be associated with increase in body weight, abdominal adiposity, and metabolic components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013303     DOI: 10.1016/j.metabol.2008.08.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

Review 1.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

2.  Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.

Authors:  Ratneev Kaur; Tajinder Kaur; Anupam Kaur
Journal:  J Assist Reprod Genet       Date:  2018-03-22       Impact factor: 3.412

3.  Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.

Authors:  Angela K Chua; Ricardo Azziz; Mark O Goodarzi
Journal:  Mol Hum Reprod       Date:  2012-01-10       Impact factor: 4.025

4.  Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.

Authors:  Tugba Unsal; Ece Konac; Ediz Yesilkaya; Akin Yilmaz; Aysun Bideci; Hacer Ilke Onen; Peyami Cinaz; Adnan Menevse
Journal:  J Assist Reprod Genet       Date:  2009-04-22       Impact factor: 3.412

5.  A cross-sectional study to assess any possible linkage of C/T polymorphism in CYP17A1 gene with insulin resistance in non-obese women with polycystic ovarian syndrome.

Authors:  Ushasi Banerjee; Anindya Dasgupta; Aparna Khan; Mrinal Kanti Ghosh; Pranab Roy; Jayanta Kumar Rout; Priyankar Roy; Suparna Dhara
Journal:  Indian J Med Res       Date:  2016-06       Impact factor: 2.375

Review 6.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

Review 7.  Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article.

Authors:  Nida Ajmal; Sanam Zeib Khan; Rozeena Shaikh
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-06-08

8.  Hyperandrogenism in POMCa-deficient zebrafish enhances somatic growth without increasing adiposity.

Authors:  Chuang Shi; Yao Lu; Gang Zhai; Jianfei Huang; Guohui Shang; Qiyong Lou; Dongliang Li; Xia Jin; Jiangyan He; Zhenyu Du; Jianfang Gui; Zhan Yin
Journal:  J Mol Cell Biol       Date:  2020-05-18       Impact factor: 6.216

9.  Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome.

Authors:  Gustavo A Rosa Maciel; Ricardo P P Moreira; Diogo D G Bugano; Sylvia A Y Hayashida; José A M Marcondes; Larissa G Gomes; Berenice B Mendonça; Tânia A S S Bachega; Edmund C Baracat
Journal:  Clinics (Sao Paulo)       Date:  2014-03       Impact factor: 2.365

Review 10.  Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management.

Authors:  Nicolas C Nicolaides; Andreas Matheou; Florentia Vlachou; Vassos Neocleous; Nicos Skordis
Journal:  Acta Biomed       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.